Cited by 22Parathyroid Disorders and TreatmentsHormonal Regulation and HypertensionCardiovascular Health and Disease Prevention

Plasma parathyroid hormone and cardiovascular disease in treatment‐naive patients with primary hyperparathyroidism: The EPATH trial

Open access
Wetzel, Julia, Pilz, Stefan, Grübler, Martin R., Fahrleitner‐Pammer, Astrid, Dimai, Hans P., von Lewinski, Dirk, Kolesnik, Ewald, Perl, Sabine +12 more·2017·The Journal of Clinical Hypertension

Abstract

Patients with primary hyperparathyroidism are at increased risk for high blood pressure, vascular stiffening, and left ventricular hypertrophy, but previous studies have failed to demonstrate the direct associations with circulating parathyroid hormone (PTH) levels. The authors investigated cross‐sectional relationships between PTH and 24‐hour pulse wave velocity, nocturnal systolic blood pressure, and left ventricular mass index in patients with primary hyperparathyroidism who were treatment‐naive with cinacalcet, renin‐angiotensin‐aldosterone‐system inhibitors, and thiazide or loop diuretics. In 76 patients, mean±SD of pulse wave velocity, nocturnal systolic blood pressure, and left ventricular mass index values were 9.3±1.8 m/s, 116.6±17.0 mm Hg, and 92.8±23.0 g/m². In multivariate linear regression analyses with adjustment for potentially confounding parameters, PTH was independently associated with nocturnal systolic blood pressure (adjusted ß coefficient=.284, P=.040), mean 24‐hour pulse wave velocity (ß=.199, P=.001), and left ventricular mass index (ß=.252, P=.025). PTH may promote vascular and cardiac remodeling in primary hyperparathyroidism. Interventional trials are needed to test the antihypertensive and cardioprotective effects of PTH‐inhibitory treatment strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jch.13064

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wetzel, J., Pilz, S., Grübler, M. R., Fahrleitner‐Pammer, A., Dimai, H. P., von Lewinski, D., Kolesnik, E., Perl, S., Trummer, C., Schwetz, V., Meinitzer, A., Belyavskiy, E., Völkl, J., Catena, C., Brandenburg, V., März, W., Pieske, B., Brussee, H., Tomaschitz, A., & Verheyen, N. D.
Affiliations
  • Universitätsklinikum Aachen (DE)
  • Medical University of Graz (AT)
  • University Hospital of Bern (CH)
  • Department of Cardiology Medical University Graz Graz Austria
  • University of Graz (AT)
  • Department of Internal Medicine Division of Endocrinology and Diabetology Medical University of Graz Graz Austria
  • Charité – Universitätsmedizin Berlin (DE)
  • Department of Cardiology Campus Virchow Charité University Berlin Germany
  • University of Udine (IT)
  • Heidelberg University (DE)
Corresponding author
  • Wetzel, Julia
  • Verheyen, Nicolas D.
Venue
The Journal of Clinical Hypertension
Publisher
Wiley
Published
2017-08-20
Volume
19
Issue
11
Pages
1173-1180
ISSN
  • 1524-6175 (ISSN-L)
  • 1751-7176
OpenAlex
W2745676945
Cited by
22
References
39
Citations by year
2025: 1 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 9 · 2019: 1 · 2017: 1
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Hypertension (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (University of Udine) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Oesterreichische Nationalbank (14621)
Topics
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
primary hyperparathyroidism, parathyroid hormone, cardiovascular disease, pulse wave velocity, left ventricular mass, vascular stiffness, left ventricular hypertrophy, vascular remodeling, cardiac remodeling, treatment-naive patients, cinacalcet, renin-angiotensin-aldosterone system inhibitors
MeSH terms
Aged, Antihypertensive Agents, Blood Pressure, Cardiotonic Agents, Cardiovascular Diseases, Echocardiography, Female, Heart Ventricles, Humans, Hypertension, Male, Middle Aged, Organ Size, Parathyroid Hormone, Blood Pressure Monitoring, Ambulatory, Hyperparathyroidism, Primary, Pulse Wave Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review